Canada markets closed

Journey Medical Corporation (DERM)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.4000-0.1000 (-2.86%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 67.77M
Enterprise Value 55.06M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.83
Price/Book (mrq)3.33
Enterprise Value/Revenue 0.70
Enterprise Value/EBITDA 28.66

Trading Information

Stock Price History

Beta (5Y Monthly) 0.81
52-Week Change 3116.56%
S&P500 52-Week Change 322.36%
52 Week High 38.1100
52 Week Low 31.0200
50-Day Moving Average 33.7312
200-Day Moving Average 33.7314

Share Statistics

Avg Vol (3 month) 3168.25k
Avg Vol (10 day) 395.86k
Shares Outstanding 513.93M
Implied Shares Outstanding 619.93M
Float 88.25M
% Held by Insiders 129.91%
% Held by Institutions 19.72%
Shares Short (Apr 15, 2024) 4235.52k
Short Ratio (Apr 15, 2024) 40.98
Short % of Float (Apr 15, 2024) 42.28%
Short % of Shares Outstanding (Apr 15, 2024) 41.18%
Shares Short (prior month Mar 15, 2024) 479.16k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -4.87%
Operating Margin (ttm)-13.79%

Management Effectiveness

Return on Assets (ttm)0.74%
Return on Equity (ttm)-20.64%

Income Statement

Revenue (ttm)79.18M
Revenue Per Share (ttm)4.34
Quarterly Revenue Growth (yoy)-4.40%
Gross Profit (ttm)N/A
EBITDA 4.84M
Net Income Avi to Common (ttm)-3.85M
Diluted EPS (ttm)-0.2100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)27.44M
Total Cash Per Share (mrq)1.38
Total Debt (mrq)17.73M
Total Debt/Equity (mrq)87.12%
Current Ratio (mrq)1.35
Book Value Per Share (mrq)1.05

Cash Flow Statement

Operating Cash Flow (ttm)5.24M
Levered Free Cash Flow (ttm)-4.7M